The antiviral drug plitidepsin could be between 10 and 100 times more effective against SARS-CoV-2, including the new UK variant, than remdesivir, finds new preclinical research involving Professor Greg Towers and Dr Clare Jolly (both UCL Infection & Immunity).
Read: i News, More: UCL News
Close
